GGrantIndex
← Leaderboards

Dana Sue Hardin

University Of Colorado Denver

Google Scholar ↗PubMed ↗ORCID ↗
$2,621,431
Attributed
$2,621,431
Total exposure
29
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $495.8K · FY2005–06
$500K$375K$250K$125K$0
'05
'06

Funding mix

By agency

NIH$2,621,431 · 29

By mechanism

R01$1,779,963 · 1
M01$841,467 · 27
R03$1 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research”

Research focus

Clinical ResearchHuman SubjectCystic FibrosisInsulin Sensitivity /ResistanceHuman Therapy EvaluationGlucose ToleranceProtein MetabolismRespiratory FunctionInsulinLongitudinal Human StudyGlucose Tolerance TestCalorimetryGluconeogenesisHuman Pregnant SubjectFemalePregnancyBioenergeticsGlucose Clamp TechniqueInterleukin 10SomatotropinProtein BiosynthesisNutrition Related TagPancreatic Islet FunctionStable Isotope

Grant awards (55)

Increased Gluconeogenesis Is One Cause of CFRD$326,494
R01 · FY2006 · DK · contact PI
EFFECT OF ATANZANAVIR IN HIV PATIENTS WITH DYSLIPIDEMIA$50,008
M01 · FY2006 · RR · contact PI
ESTABLISHING THE PRECURSORS OF THE METABOLIC SYNDROME IN CHILDREN$28,930
M01 · FY2006 · RR · contact PI
GROWTH HORMONE USE IN ADOLESCENTS AND ADULTS WITH CYSTIC FIBROSIS$23,321
M01 · FY2006 · RR · contact PI
USE OF NUTROPIN DEPOT IN HIV-INFECTED ADULT MALES$5,001
M01 · FY2006 · RR · contact PI
EFFECTS OF GROWTH HORMONE IN CHRONICALLY ILL CHILDREN$3,542
M01 · FY2006 · RR · contact PI
METABOLIC ABNORMALITIES IN HISPANIC CHILDREN WITH CYSTIC FIBROSIS$2,952
M01 · FY2006 · RR · contact PI
INGESTED IFN-ALPHA IN NEWLY DIAGNOSED TYPE I DIABETES$2,066
M01 · FY2006 · RR · contact PI
USE OF INSULIN PUMP IN CYSTIC FIBROSIS$591
M01 · FY2006 · RR · contact PI
Increased Gluconeogenesis Is One Cause of CFRD$212,118
R01 · FY2005 · DK
Increased Gluconeogenesis Is One Cause of CFRD$132,775
R01 · FY2005 · DK
EFFECT OF ATANZANAVIR IN HIV PATIENTS WITH DYSLIPIDEMIA$44,756
M01 · FY2005 · RR
GROWTH HORMONE USE IN ADOLESCENTS AND ADULTS WITH CYSTIC FIBROSIS$33,265
M01 · FY2005 · RR
USE OF NUTROPIN DEPOT IN HIV-INFECTED ADULT MALES$27,973
M01 · FY2005 · RR
METABOLIC ABNORMALITIES IN HISPANIC CHILDREN WITH CYSTIC FIBROSIS$25,126
M01 · FY2005 · RR
INGESTED IFN-ALPHA IN NEWLY DIAGNOSED TYPE I DIABETES$8,847
M01 · FY2005 · RR
ESTABLISHING THE PRECURSORS OF THE METABOLIC SYNDROME IN CHILDREN$7,432
M01 · FY2005 · RR
EFFECTS OF GROWTH HORMONE IN CHRONICALLY ILL CHILDREN$3,538
M01 · FY2005 · RR
Increased Gluconeogenesis Is One Cause of CFRD$362,213
R01 · FY2004 · DK
USE OF NUTROPIN DEPOT IN HIV-INFECTED ADULT MALES$18,071
M01 · FY2004 · RR
Gluconeogenesis and De novo Lipogenesis in Cystic Fibrosis$15,282
M01 · FY2004 · RR
Growth Hormone Use in Adolescents and Adults with Cystic Fibrosis$13,953
M01 · FY2004 · RR
Ingested IFN-Alpha in Newly Diagnosed Type I Diabetes$5,094
M01 · FY2004 · RR
Metabolic abnormalities in Hispanic children with cystic fibrosis$4,651
M01 · FY2004 · RR
Use of Insulin Pump in Cystic Fibrosis$886
M01 · FY2004 · RR
Effects of growth hormone in chronically ill children$664
M01 · FY2004 · RR
Increased Gluconeogenesis Is One Cause of CFRD$362,213
R01 · FY2003 · DK
Increased Gluconeogenesis Is One Cause of CFRD$384,150
R01 · FY2002 · DK
METABOLIC EFFECTS OF PREGNANCY IN CYSTIC FIBROSIS (SS)$190,747
M01 · FY2002 · RR
Insulin pump usage in cystic fibrosis patients with impaired glucose tolerance$0
M01 · FY2002 · RR
Insulin action in AIDS$0
M01 · FY2002 · RR
EFFECTS OF NUTRITIONAL SUPPLEMENTATION ON BETA CELL FUNCTION IN CYSTIC FIBROSIS$0
M01 · FY2002 · RR
METABOLIC EFFECTS OF PREGNANCY IN CYSTIC FIBROSIS$0
M01 · FY2002 · RR
GROWTH HORMONE IMPROVES THE CLINICAL STATUS OF MALNOURISHED CF PATIENTS$0
M01 · FY2002 · RR
USE OF METFORMIN TO TREAT INSULIN RESISTANCE AND OBESITY$0
M01 · FY2002 · RR
METABOLIC EFFECTS OF PREGNANCY IN CYSTIC FIBROSIS (SS)$190,747
M01 · FY2001 · RR
Insulin pump usage in cystic fibrosis patients with impaired glucose tolerance$0
M01 · FY2001 · RR
Insulin action in AIDS$0
M01 · FY2001 · RR
EFFECTS OF NUTRITIONAL SUPPLEMENTATION ON BETA CELL FUNCTION IN CYSTIC FIBROSIS$0
M01 · FY2001 · RR
METABOLIC EFFECTS OF PREGNANCY IN CYSTIC FIBROSIS$0
M01 · FY2001 · RR
GROWTH HORMONE IMPROVES THE CLINICAL STATUS OF MALNOURISHED CF PATIENTS$0
M01 · FY2001 · RR
USE OF METFORMIN TO TREAT INSULIN RESISTANCE AND OBESITY$0
M01 · FY2001 · RR
METABOLIC EFFECTS OF PREGNANCY IN CYSTIC FIBROSIS (SS)$0
M01 · FY2001 · RR
METABOLIC EFFECTS OF PREGNANCY IN CYSTIC FIBROSIS (SS)$32,212
M01 · FY2000 · RR
EFFECT OF PROTEASE INHIBITORS ON WHOLE BODY PROTEIN TURNOVER IN AIDS CHILDREN$15,114
M01 · FY2000 · RR
GLUCOSE INTOLERANCE AND DIABETES MELLITUS IN PATIENTS WITH CYSTIC FIBROSIS$15,114
M01 · FY2000 · RR
USE OF METFORMIN TO TREAT INSULIN RESISTANCE AND OBESITY$15,114
M01 · FY2000 · RR
GROWTH HORMONE IMPROVES THE CLINICAL STATUS OF MALNOURISHED CF PATIENTS$15,114
M01 · FY2000 · RR
METABOLIC EFFECTS OF PREGNANCY IN CYSTIC FIBROSIS$15,114
M01 · FY2000 · RR
RED BLOOD CELL TURNOVER IN CYSTIC FIBROSIS PATIENTS$15,114
M01 · FY2000 · RR
EFFECTS OF NUTRITIONAL SUPPLEMENTATION ON BETA CELL FUNCTION IN CYSTIC FIBROSIS$11,128
M01 · FY2000 · RR
GLUCONEOGENESIS &DE NOVO LIPOGENESIS IN CYSTIC FIBROSIS$1
R03 · FY2000 · DK
Insulin action in AIDS$0
M01 · FY2000 · RR
Insulin pump usage in cystic fibrosis patients with impaired glucose tolerance$0
M01 · FY2000 · RR
METABOLIC EFFECTS OF PREGNANCY IN CYSTIC FIBROSIS (SS)$0
M01 · FY2000 · RR